On 28 April 2022, CHIL successfully obtained CE certification for its COVID-19 Antigen Test after completing a comprehensive audit conducted by a European Notified Body.
The certification was granted following a detailed assessment of the company’s quality management system, technical documentation, manufacturing processes, and product performance. This achievement confirms that CHIL’s COVID-19 Antigen Test meets the required European regulatory standards for safety, performance, and compliance.
The milestone further strengthens CHIL’s position in international markets and reflects the company’s commitment to maintaining high regulatory and quality standards in diagnostic manufacturing.